Are you Dr. Hetzel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
685 S Dobson Rd
Chandler, AZ 85224Phone+1 480-324-5220Fax+1 480-257-1998
Summary
- Dr. David Hetzel, MD is an obstetrician/gynecologist in Chandler, Arizona. He is currently licensed to practice medicine in Florida, New York, and Texas.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Obstetrics and Gynecology, 1988 - 1992
- Medical College of WisconsinClass of 1988
Certifications & Licensure
- FL State Medical License 2023 - 2026
- NC State Medical License 1997 - 2025
- NY State Medical License 2023 - 2025
- TX State Medical License 2020 - 2024
- WI State Medical License 1994 - 2021
- PA State Medical License 1992 - 2014
- TN State Medical License 1997 - 2013
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2014
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2007 Jul 01
- PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsEntyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.Webber Chan, Nicole Lynch, Peter A. Bampton, Jeff Chang, Alvin Ru Tien Chung
European Journal of Gastroenterology & Hepatology. 2018-01-01 - 9 citationsCurrent advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancerMary L. Gemignani, David J. Hetzel
Gynecologic Oncology. 2017-10-01 - 1 citationsSurgical and Locoregional Treatment of DCIS and Early-Invasive Breast Cancer.David J. Hetzel
Clinical Obstetrics and Gynecology. 2016-12-01
Professional Memberships
- Member
- Fellow
- Member